MY197281A - Oral composite tablet comprising ezetimibe and rosuvastatin - Google Patents

Oral composite tablet comprising ezetimibe and rosuvastatin

Info

Publication number
MY197281A
MY197281A MYPI2019002029A MYPI2019002029A MY197281A MY 197281 A MY197281 A MY 197281A MY PI2019002029 A MYPI2019002029 A MY PI2019002029A MY PI2019002029 A MYPI2019002029 A MY PI2019002029A MY 197281 A MY197281 A MY 197281A
Authority
MY
Malaysia
Prior art keywords
rosuvastatin
ezetimibe
composite tablet
water
oral composite
Prior art date
Application number
MYPI2019002029A
Other languages
English (en)
Inventor
Jae Hyun Park
Jong Soo Woo
Yong Il Kim
Jung Hyun Cho
Jin Cheul Kim
Han Byul Song
Original Assignee
Hanmi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62241643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY197281(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharma Co Ltd filed Critical Hanmi Pharma Co Ltd
Publication of MY197281A publication Critical patent/MY197281A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI2019002029A 2016-11-29 2017-11-24 Oral composite tablet comprising ezetimibe and rosuvastatin MY197281A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160160513A KR102206535B1 (ko) 2016-11-29 2016-11-29 에제티미브 및 로수바스타틴을 포함하는 경구용 복합정제
PCT/KR2017/013508 WO2018101681A1 (en) 2016-11-29 2017-11-24 Oral composite tablet comprising ezetimibe and rosuvastatin

Publications (1)

Publication Number Publication Date
MY197281A true MY197281A (en) 2023-06-09

Family

ID=62241643

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019002029A MY197281A (en) 2016-11-29 2017-11-24 Oral composite tablet comprising ezetimibe and rosuvastatin

Country Status (8)

Country Link
KR (1) KR102206535B1 (es)
BR (1) BR112019010706A2 (es)
CL (1) CL2019001424A1 (es)
EC (1) ECSP19037610A (es)
MX (1) MX2019006148A (es)
MY (1) MY197281A (es)
SG (1) SG11201903261VA (es)
WO (1) WO2018101681A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022001783A2 (pt) 2019-07-31 2022-03-22 Tecnimede Sociedade Tecnico Medicinal Sa Composições orais sólidas multiunitárias de liberação imediata, seus métodos e usos.
KR20250161310A (ko) * 2024-05-08 2025-11-17 한미약품 주식회사 복약순응도가 개선된 에제티미브, 로수바스타틴 및 엠파글리플로진을 포함하는 복합제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009024889A2 (en) 2007-08-21 2009-02-26 Ranbaxy Laboratories Limited Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe
ES2802252T3 (es) 2012-05-01 2021-01-18 Althera Life Sciences Llc Formulación de comprimido oral que consiste en la combinación fija de rosuvastatina y ezetimiba para el tratamiento de hiperlipidemia y enfermedades cardiovasculares
KR20150079373A (ko) * 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
KR101977785B1 (ko) * 2014-06-25 2019-05-14 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법
KR101834559B1 (ko) * 2015-02-27 2018-03-06 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 고형 복합제제

Also Published As

Publication number Publication date
CL2019001424A1 (es) 2019-10-04
BR112019010706A2 (pt) 2019-10-01
MX2019006148A (es) 2019-08-14
WO2018101681A1 (en) 2018-06-07
SG11201903261VA (en) 2019-05-30
ECSP19037610A (es) 2019-06-30
KR102206535B1 (ko) 2021-01-22
KR20180060705A (ko) 2018-06-07

Similar Documents

Publication Publication Date Title
MY187637A (en) Composite formulation for oral administration comprising ezetimibe and rosuvastatin
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
SG10201811586YA (en) Composite formulation for oral administration comprising ezetimibe and rosuvastatin and a process for the preparation thereof
GEP20197003B (en) Aminopyrimidinyl compounds as jak inhibitors
SG11201606615QA (en) 2,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefrom
MX2014011815A (es) Composiciones farmaceuticas de liberacion inmediata con propiedades disuasivas de abuso.
PH12012501792A1 (en) Process for preparing carrier particles for dry powders for inhalation
WO2016098054A9 (en) Processes for preparing oxathiazin-like compounds
MY186698A (en) Solid forms of ceftolozane
EP3173412A4 (en) 2,4-disubstituted 7h-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof
SG10201908582TA (en) 1,2-substituted cyclopentanes as orexin receptor antagonists
MX2013007587A (es) Suplementos alimenticios en particulas medicados para animales y metodos de preparacion.
MX2018011799A (es) Formas de dosificacion de liberacion prolongada disuasivas de abuso.
EP3385306A4 (en) Composite particles including cellulose, inorganic compound, and hydroxypropyl cellulose
WO2017093783A8 (en) Network security agent
WO2015173701A3 (en) Pharmaceutical compositions comprising danirixin for treating infectious diseases
EP3560931B8 (en) PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND CO-CRYSTALS THEREOF
EP4647068A3 (en) Formulations of ag10
MY197281A (en) Oral composite tablet comprising ezetimibe and rosuvastatin
AU2014226192A8 (en) Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
AU2016204261A1 (en) Taste-masked formulations of raltegravir
WO2015178608A3 (ko) 3,4-디히드로퀴나졸린 유도체 및 그를 포함하는 복합제
WO2016071405A3 (en) Pharmaceutical preparation and method of its production and use
PH12019550098A1 (en) Nutritional composition in powder form provided in single serving capsules
MY194438A (en) Modified streptomyces fungicidicus isolates and their use